{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ei6aG488lCjV"
      },
      "outputs": [],
      "source": [
        "!pip install groq"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "vK7H7wIxlE8h"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "from tqdm import tqdm\n",
        "\n",
        "import re\n",
        "import requests\n",
        "import json\n",
        "import time\n",
        "import copy\n",
        "from typing import Dict, Any"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# ClinicalTrials.gov Fetcher (Data Acquisition Layer)\n",
        "\n",
        "Programmatically fetch lung-cancer clinical trial metadata from ClinicalTrials.gov using their API, with pagination, filtering, and safety control (timeouts, progress bars)."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "nU2z-MhJlE_Q",
        "outputId": "2bed753f-ce1e-4736-f874-ec490890b06e"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "Fetching lung cancer trials: 100trial [00:00, 104.23trial/s]"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "Fetched 100 lung cancer trials\n",
            "Done!\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "\n"
          ]
        }
      ],
      "source": [
        "\n",
        "# ============= LUNG CANCER-ONLY FETCHER =============\n",
        "BASE_URL = \"https://clinicaltrials.gov/api/v2/studies\"\n",
        "\n",
        "def fetch_lung_cancer_trials(\n",
        "    page_size=10,\n",
        "    max_total=50,\n",
        "    status_filter=None         # e.g., \"RECRUITING\", \"ACTIVE_NOT_RECRUITING\"\n",
        "):\n",
        "    \n",
        "\n",
        "        \n",
        "    params = {\n",
        "        \"format\": \"json\",\n",
        "        \"pageSize\": page_size,\n",
        "        # MeSH filter for lung neoplasms\n",
        "        \"filter.advanced\": \"AREA[ConditionMeshTerm]Neoplasms/Lung\",\n",
        "    }\n",
        "    if status_filter:\n",
        "        params[\"filter.status\"] = status_filter\n",
        "\n",
        "    all_studies = []\n",
        "    next_token = None\n",
        "    pbar = tqdm(desc=\"Fetching lung cancer trials\", unit=\"trial\")\n",
        "\n",
        "    while True:\n",
        "        if next_token:\n",
        "            params[\"pageToken\"] = next_token  #Token-based pagination (not offset pagination) → stable & scalable.\n",
        "\n",
        "        resp = requests.get(BASE_URL, params=params, timeout=60)\n",
        "        resp.raise_for_status()\n",
        "        data = resp.json()\n",
        "\n",
        "        batch = data.get(\"studies\", [])\n",
        "        all_studies.extend(batch)\n",
        "        pbar.update(len(batch))\n",
        "\n",
        "        next_token = data.get(\"nextPageToken\")\n",
        "        if not next_token or (max_total and len(all_studies) >= max_total):\n",
        "            break\n",
        "\n",
        "        time.sleep(0.1)\n",
        "\n",
        "    pbar.close()\n",
        "    studies = all_studies[:max_total] if max_total else all_studies\n",
        "    print(f\"\\nFetched {len(studies)} lung cancer trials\")\n",
        "    return studies\n",
        "\n",
        "# Usage\n",
        "studies = fetch_lung_cancer_trials(\n",
        "    page_size=100,\n",
        "    max_total=100,\n",
        "    # status_filter=\"RECRUITING|ACTIVE_NOT_RECRUITING\"  # optional\n",
        ")\n",
        "\n",
        "\n",
        "print(\"Done!\")\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Flattening & Preprocessing Clinical Trial Records\n",
        "\n",
        "Transforming messy, nested API responses into clean, machine-friendly tabular structures\n",
        "for downstream modeling, LLM extraction, and DataFrame storage.\n",
        "\n",
        "The ClinicalTrials.gov API returns nested JSON structure, arrays inside dictionaries inside arrays\n",
        "But for ML workflows, we need flat rows, such as:\n",
        "| nct_id | title | status | eligibility_text | conditions | locations | ... |\n",
        "\n",
        "This is what the next preprocessing code accomplish."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Ru7efwoJlFCA",
        "outputId": "88591cef-b35d-4ffa-8f8e-41bdad5184a2"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Raw df shape: (100, 19)\n"
          ]
        }
      ],
      "source": [
        "# Flatten helper\n",
        "def safe_get(d, path, default=\"\"):\n",
        "\n",
        "    \"\"\"\n",
        "    Safely retrieve a value from a nested dictionary using a list of keys.\n",
        "\n",
        "    Args:\n",
        "        d (dict): The dictionary to traverse (can be None or non-dict at any level)\n",
        "        path (list): Sequence of keys, e.g. [\"designModule\", \"phases\", \"current\"]\n",
        "        default: Value returned if any key is missing or a non-dict is encountered\n",
        "\n",
        "    Returns:\n",
        "        The value at the given path, or `default` if the path cannot be followed.\n",
        "    \"\"\"\n",
        "\n",
        "    for p in path:\n",
        "        if not isinstance(d, dict):\n",
        "            return default\n",
        "        d = d.get(p, default)\n",
        "    return d if d is not None else default\n",
        "\n",
        "\n",
        "# Flattening\n",
        "\n",
        "\"\"\"    \n",
        "Phases and Conditions can be lists and can be a single value the code bellow \n",
        "Ensures consistent string representation by Joining list values with \", \" \n",
        "if the target not a list return the single value (or empty string)\n",
        "\"\"\"\n",
        "\n",
        "records = []\n",
        "for s in studies:\n",
        "    ps = s.get(\"protocolSection\", {})\n",
        "\n",
        "    row = {\n",
        "        \"NCT_ID\": safe_get(ps, [\"identificationModule\", \"nctId\"]),\n",
        "        \"Title\": safe_get(ps, [\"identificationModule\", \"briefTitle\"]),\n",
        "        \"Official_Title\": safe_get(ps, [\"identificationModule\", \"officialTitle\"]),\n",
        "        \"Status\": safe_get(ps, [\"statusModule\", \"overallStatus\"]),\n",
        "        \"Start_Date\": safe_get(ps, [\"statusModule\", \"startDateStruct\", \"date\"]),\n",
        "        \"Primary_Completion\": safe_get(ps, [\"statusModule\", \"primaryCompletionDateStruct\", \"date\"]),\n",
        "        \"Study_Type\": safe_get(ps, [\"designModule\", \"studyType\"]),\n",
        "        \"Phases\": \", \".join(safe_get(ps, [\"designModule\", \"phases\"], [])) if isinstance(safe_get(ps, [\"designModule\", \"phases\"], []), list) else safe_get(ps, [\"designModule\", \"phases\"], \"\"),\n",
        "        \"Enrollment\": safe_get(ps, [\"designModule\", \"enrollmentInfo\", \"count\"]),\n",
        "        \"Conditions\": \", \".join(safe_get(ps, [\"conditionsModule\", \"conditions\"], [])) if isinstance(safe_get(ps, [\"conditionsModule\", \"conditions\"], []), list) else safe_get(ps, [\"conditionsModule\", \"conditions\"], \"\"),\n",
        "        \"Sex\": safe_get(ps, [\"eligibilityModule\", \"sex\"]),\n",
        "        \"Min_Age\": safe_get(ps, [\"eligibilityModule\", \"minimumAge\"]),\n",
        "        \"Max_Age\": safe_get(ps, [\"eligibilityModule\", \"maximumAge\"]),\n",
        "        \"Lead_Sponsor\": safe_get(ps, [\"sponsorCollaboratorsModule\", \"leadSponsor\", \"name\"]),\n",
        "        \"Brief_Summary\": safe_get(ps, [\"descriptionModule\", \"briefSummary\"]),\n",
        "        \"Eligibility\": safe_get(ps, [\"eligibilityModule\", \"eligibilityCriteria\"]),\n",
        "    }\n",
        "    # outcomes & interventions always lists\n",
        "    prim = safe_get(ps, [\"outcomesModule\", \"primaryOutcomes\"], [])\n",
        "    row[\"Primary_Measures\"] = \" | \".join([p.get(\"measure\", \"\") for p in prim]) if prim else \"\"\n",
        "    sec = safe_get(ps, [\"outcomesModule\", \"secondaryOutcomes\"], [])\n",
        "    row[\"Secondary_Measures\"] = \" | \".join([p.get(\"measure\", \"\") for p in sec]) if sec else \"\"\n",
        "    ints = safe_get(ps, [\"armsInterventionsModule\", \"interventions\"], [])\n",
        "    row[\"Interventions\"] = \" | \".join([f\"{i.get('type','')}:{i.get('name','')}\" for i in ints]) if ints else \"\"\n",
        "    records.append(row)\n",
        "\n",
        "df = pd.DataFrame(records)\n",
        "print(\"Raw df shape:\", df.shape)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Clinical Trial Text Normalization\n",
        "\n",
        "Cleaning and Normalizing raw textual fields, especially the eligibility criteria by removing artifacts, whitespace noise, and metadata markup."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_X5nKXmulFEy"
      },
      "outputs": [],
      "source": [
        "# ============= Clean text ============\n",
        "def clean_text(t):\n",
        "    if not isinstance(t, str): return \"\"\n",
        "    t = re.sub(r\"\\s+\", \" \", t)\n",
        "    t = re.sub(r\"[•\\n\\t\\r]\", \" \", t)\n",
        "    t = re.sub(r\"\\(Version [^\\)]*\\)\", \"\", t)\n",
        "    return t.strip()\n",
        "\n",
        "for col in [\"Title\", \"Brief_Summary\", \"Official_Title\", \"Eligibility\"]:\n",
        "    if col in df.columns:\n",
        "        df[col] = df[col].apply(clean_text)\n",
        "\n",
        "# adding eligibility length field\n",
        "df[\"elig_len\"] = df[\"Eligibility\"].apply(lambda x: len(x or \"\"))\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 608
        },
        "id": "noqQZCCxlFHB",
        "outputId": "788d62db-c053-494c-8141-3845b7e60e76"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 100,\n  \"fields\": [\n    {\n      \"column\": \"NCT_ID\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"NCT04657120\",\n          \"NCT00003587\",\n          \"NCT02840578\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Title\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy\",\n          \"S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer\",\n          \"NK Cell Activity in Smokers Screened for Lung Cancer\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Official_Title\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 99,\n        \"samples\": [\n          \"Lateral Surgical Positioning for Thoracic Surgery -Effect on Ipsilateral Shoulder Pain?\",\n          \"The Randomized Controlled Clinical Trial of Kushen Injection Reducing Radiotherapy Related Adverse Reactions in Lung Cancer\",\n          \"Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Status\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 9,\n        \"samples\": [\n          \"AVAILABLE\",\n          \"RECRUITING\",\n          \"UNKNOWN\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Start_Date\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 93,\n        \"samples\": [\n          \"2025-05-22\",\n          \"2023-11\",\n          \"2025-06-21\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Primary_Completion\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 93,\n        \"samples\": [\n          \"2019-01-25\",\n          \"2025-11\",\n          \"2010-09\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Study_Type\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"INTERVENTIONAL\",\n          \"OBSERVATIONAL\",\n          \"EXPANDED_ACCESS\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Phases\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 9,\n        \"samples\": [\n          \"PHASE3\",\n          \"PHASE2\",\n          \"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Enrollment\",\n      \"properties\": {\n        \"dtype\": \"date\",\n        \"min\": \"1970-01-01 00:00:00\",\n        \"max\": \"1970-01-01 00:00:00.000009613\",\n        \"num_unique_values\": 71,\n        \"samples\": [\n          105,\n          50,\n          53\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Conditions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 73,\n        \"samples\": [\n          \"Lung Cancer, Brain Tumor, Liver Cancer, Ovarian Cancer\",\n          \"PD-L1-positive Metastatic NSCLC\",\n          \"Small Cell Lung Cancer, Ovarian Cancer, Solid Tumors\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Sex\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"ALL\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Min_Age\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 11,\n        \"samples\": [\n          \"15 Years\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Max_Age\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 11,\n        \"samples\": [\n          \"99 Years\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Lead_Sponsor\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 90,\n        \"samples\": [\n          \"Creative Biosciences (Guangzhou) Co., Ltd.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Brief_Summary\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"The aim of this study is to prospectively validate the safety and efficiency of management according to the YEARS algorithm to safely rule out clinically suspected PE in patients with active malignancy to be compared with 'standard' management by computed tomography pulmonary angiography (CTPA) alone in a randomized study.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Eligibility\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 100,\n        \"samples\": [\n          \"Inclusion Criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Clinically suspected PE as judged by the treating clinician * Any type of active malignancy (other than basal-cell or squamous-cell carcinoma of the skin), defined as diagnosis within six months before the study inclusion (as confirmed histologically or high suspicion as judged by the clinician), receiving treatment for malignancy at time of inclusion or during 6 months prior to randomization, including recurrent or local metastatic malignancy * Outpatients and hospitalized patients * Age \\u2265 18 years * Signed and dated informed consent, available for start of the trial procedure Exclusion Criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * Medical or psychological condition that would not permit completion of the study or signing of informed consent, including life expectancy less than 3 months, or unwillingness to sign informed consent * Treatment with full-dose therapeutically dosed anticoagulation that was initiated 24 hours or more prior to eligibility assessment * Contraindication to CTPA * contrast allergy Hemodynamic instability at presentation (as a consequence of concurrent acute PE or otherwise), indicated by at least one of the following: * systolic blood pressure (SBP) \\\\< 100 mm Hg, or heart rate \\\\>120 beats per minute or SBP drop by \\\\> 40 mm Hg, for \\\\> 15 min * need for catecholamines to maintain adequate organ perfusion and a systolic blood pressure of \\\\> 100 mmHg * Need for cardiopulmonary resuscitation * Inability to follow-up * Life expectancy less than 3 months\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Primary_Measures\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 93,\n        \"samples\": [\n          \"Sensitivity | Specificity | Consistency Rate | Kappa Coefficient\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Secondary_Measures\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 69,\n        \"samples\": [\n          \"Overall Survival | Objective Response Rate\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Interventions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 83,\n        \"samples\": [\n          \"DRUG:Durvalumab\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"elig_len\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 3071,\n        \"min\": 87,\n        \"max\": 13427,\n        \"num_unique_values\": 98,\n        \"samples\": [\n          348\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "df"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-e50050ae-1c01-4149-b104-da15b08ad5c5\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NCT_ID</th>\n",
              "      <th>Title</th>\n",
              "      <th>Official_Title</th>\n",
              "      <th>Status</th>\n",
              "      <th>Start_Date</th>\n",
              "      <th>Primary_Completion</th>\n",
              "      <th>Study_Type</th>\n",
              "      <th>Phases</th>\n",
              "      <th>Enrollment</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>Sex</th>\n",
              "      <th>Min_Age</th>\n",
              "      <th>Max_Age</th>\n",
              "      <th>Lead_Sponsor</th>\n",
              "      <th>Brief_Summary</th>\n",
              "      <th>Eligibility</th>\n",
              "      <th>Primary_Measures</th>\n",
              "      <th>Secondary_Measures</th>\n",
              "      <th>Interventions</th>\n",
              "      <th>elig_len</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NCT01189968</td>\n",
              "      <td>A Study of Carboplatin and Pemetrexed Plus Dem...</td>\n",
              "      <td>A Phase 1b Study of Carboplatin and Pemetrexed...</td>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>2010-09</td>\n",
              "      <td>2016-09</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>PHASE1</td>\n",
              "      <td>50</td>\n",
              "      <td>Non Small Cell Lung Cancer</td>\n",
              "      <td>ALL</td>\n",
              "      <td>21 Years</td>\n",
              "      <td></td>\n",
              "      <td>OncoMed Pharmaceuticals, Inc.</td>\n",
              "      <td>The purpose of this study is to test the safet...</td>\n",
              "      <td>Inclusion criteria 1. Subjects must have histo...</td>\n",
              "      <td>To the determine the maximum tolerated dose of...</td>\n",
              "      <td>To determine the safety of carboplatin and pem...</td>\n",
              "      <td>DRUG:Demcizumab</td>\n",
              "      <td>4781</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NCT03199586</td>\n",
              "      <td>Clinical Trial of Metastasis Inhibitor NP-G2-0...</td>\n",
              "      <td>First-in-Human, Dose Finding, Open Label Phase...</td>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>2017-12-21</td>\n",
              "      <td>2020-05-07</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>PHASE1</td>\n",
              "      <td>23</td>\n",
              "      <td>Breast Cancer, Pancreas Cancer, Prostate Cance...</td>\n",
              "      <td>ALL</td>\n",
              "      <td>18 Years</td>\n",
              "      <td></td>\n",
              "      <td>Novita Pharmaceuticals, Inc.</td>\n",
              "      <td>Phase 1 A: First-in-human phase 1 study to det...</td>\n",
              "      <td>Inclusion Criteria: 1. Signed informed consent...</td>\n",
              "      <td>Establish the safe recommended phase 2 dose</td>\n",
              "      <td>Identify and characterize preliminary anti tum...</td>\n",
              "      <td>DRUG:NP-G2-044</td>\n",
              "      <td>3702</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NCT00305786</td>\n",
              "      <td>Gemcitabine and Oxaliplatin as Second-Line The...</td>\n",
              "      <td>Phase II Study of Oxaliplatin in Combination W...</td>\n",
              "      <td>COMPLETED</td>\n",
              "      <td>2005-08</td>\n",
              "      <td>2007-12</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>PHASE2</td>\n",
              "      <td>30</td>\n",
              "      <td>Lung Cancer</td>\n",
              "      <td>ALL</td>\n",
              "      <td>18 Years</td>\n",
              "      <td>120 Years</td>\n",
              "      <td>University of Miami</td>\n",
              "      <td>RATIONALE: Drugs used in chemotherapy, such as...</td>\n",
              "      <td>DISEASE CHARACTERISTICS: * Histologically prov...</td>\n",
              "      <td>Response rate as measured by RECIST criteria</td>\n",
              "      <td>Toxicity as monitored by DSMC</td>\n",
              "      <td>DRUG:gemcitabine hydrochloride | DRUG:oxaliplatin</td>\n",
              "      <td>2228</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NCT06508307</td>\n",
              "      <td>A Phase I Clinical Study of Intratumoral Injec...</td>\n",
              "      <td>A Phase I Study Evaluating the Safety, Tolerab...</td>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>2023-04-26</td>\n",
              "      <td>2026-01</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>PHASE1</td>\n",
              "      <td>21</td>\n",
              "      <td>Sarcoma, Cervical Cancer, Colon Cancer, Lung C...</td>\n",
              "      <td>ALL</td>\n",
              "      <td>18 Years</td>\n",
              "      <td>75 Years</td>\n",
              "      <td>GONGCHU Biotechnology Co., Ltd</td>\n",
              "      <td>The present trial is an open, single-arm phase...</td>\n",
              "      <td>Inclusion Criteria: To be eligible for partici...</td>\n",
              "      <td>Evaluate the safety and tolerability of GC001 ...</td>\n",
              "      <td>Anti-tumor activity of GC001: overall response...</td>\n",
              "      <td>BIOLOGICAL:A Phase I Clinical Study of Intratu...</td>\n",
              "      <td>8665</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NCT05926336</td>\n",
              "      <td>The Effects of Using Different Anesthetics on ...</td>\n",
              "      <td>To Compare the Effects of Intraoperative Use o...</td>\n",
              "      <td>RECRUITING</td>\n",
              "      <td>2023-05-23</td>\n",
              "      <td>2026-07</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>PHASE4</td>\n",
              "      <td>1316</td>\n",
              "      <td>Lung Cancer, Brain Tumor, Liver Cancer, Ovaria...</td>\n",
              "      <td>ALL</td>\n",
              "      <td>20 Years</td>\n",
              "      <td>80 Years</td>\n",
              "      <td>Kaohsiung Medical University Chung-Ho Memorial...</td>\n",
              "      <td>1. Eligible participants were assessed prior t...</td>\n",
              "      <td>Inclusion Criteria: * eighteen to eighty-year-...</td>\n",
              "      <td>Overall survival | The presence of disease pro...</td>\n",
              "      <td>Postoperative complications | Karnofsky perfor...</td>\n",
              "      <td>DRUG:Propofol | DRUG:Sevoflurane</td>\n",
              "      <td>726</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-e50050ae-1c01-4149-b104-da15b08ad5c5')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-e50050ae-1c01-4149-b104-da15b08ad5c5 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-e50050ae-1c01-4149-b104-da15b08ad5c5');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-0eccf656-e5b6-4af0-861a-c54e6f6f1ed1\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-0eccf656-e5b6-4af0-861a-c54e6f6f1ed1')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-0eccf656-e5b6-4af0-861a-c54e6f6f1ed1 button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "        NCT_ID                                              Title  \\\n",
              "0  NCT01189968  A Study of Carboplatin and Pemetrexed Plus Dem...   \n",
              "1  NCT03199586  Clinical Trial of Metastasis Inhibitor NP-G2-0...   \n",
              "2  NCT00305786  Gemcitabine and Oxaliplatin as Second-Line The...   \n",
              "3  NCT06508307  A Phase I Clinical Study of Intratumoral Injec...   \n",
              "4  NCT05926336  The Effects of Using Different Anesthetics on ...   \n",
              "\n",
              "                                      Official_Title      Status  Start_Date  \\\n",
              "0  A Phase 1b Study of Carboplatin and Pemetrexed...   COMPLETED     2010-09   \n",
              "1  First-in-Human, Dose Finding, Open Label Phase...   COMPLETED  2017-12-21   \n",
              "2  Phase II Study of Oxaliplatin in Combination W...   COMPLETED     2005-08   \n",
              "3  A Phase I Study Evaluating the Safety, Tolerab...  RECRUITING  2023-04-26   \n",
              "4  To Compare the Effects of Intraoperative Use o...  RECRUITING  2023-05-23   \n",
              "\n",
              "  Primary_Completion      Study_Type  Phases Enrollment  \\\n",
              "0            2016-09  INTERVENTIONAL  PHASE1         50   \n",
              "1         2020-05-07  INTERVENTIONAL  PHASE1         23   \n",
              "2            2007-12  INTERVENTIONAL  PHASE2         30   \n",
              "3            2026-01  INTERVENTIONAL  PHASE1         21   \n",
              "4            2026-07  INTERVENTIONAL  PHASE4       1316   \n",
              "\n",
              "                                          Conditions  Sex   Min_Age  \\\n",
              "0                         Non Small Cell Lung Cancer  ALL  21 Years   \n",
              "1  Breast Cancer, Pancreas Cancer, Prostate Cance...  ALL  18 Years   \n",
              "2                                        Lung Cancer  ALL  18 Years   \n",
              "3  Sarcoma, Cervical Cancer, Colon Cancer, Lung C...  ALL  18 Years   \n",
              "4  Lung Cancer, Brain Tumor, Liver Cancer, Ovaria...  ALL  20 Years   \n",
              "\n",
              "     Max_Age                                       Lead_Sponsor  \\\n",
              "0                                 OncoMed Pharmaceuticals, Inc.   \n",
              "1                                  Novita Pharmaceuticals, Inc.   \n",
              "2  120 Years                                University of Miami   \n",
              "3   75 Years                     GONGCHU Biotechnology Co., Ltd   \n",
              "4   80 Years  Kaohsiung Medical University Chung-Ho Memorial...   \n",
              "\n",
              "                                       Brief_Summary  \\\n",
              "0  The purpose of this study is to test the safet...   \n",
              "1  Phase 1 A: First-in-human phase 1 study to det...   \n",
              "2  RATIONALE: Drugs used in chemotherapy, such as...   \n",
              "3  The present trial is an open, single-arm phase...   \n",
              "4  1. Eligible participants were assessed prior t...   \n",
              "\n",
              "                                         Eligibility  \\\n",
              "0  Inclusion criteria 1. Subjects must have histo...   \n",
              "1  Inclusion Criteria: 1. Signed informed consent...   \n",
              "2  DISEASE CHARACTERISTICS: * Histologically prov...   \n",
              "3  Inclusion Criteria: To be eligible for partici...   \n",
              "4  Inclusion Criteria: * eighteen to eighty-year-...   \n",
              "\n",
              "                                    Primary_Measures  \\\n",
              "0  To the determine the maximum tolerated dose of...   \n",
              "1        Establish the safe recommended phase 2 dose   \n",
              "2       Response rate as measured by RECIST criteria   \n",
              "3  Evaluate the safety and tolerability of GC001 ...   \n",
              "4  Overall survival | The presence of disease pro...   \n",
              "\n",
              "                                  Secondary_Measures  \\\n",
              "0  To determine the safety of carboplatin and pem...   \n",
              "1  Identify and characterize preliminary anti tum...   \n",
              "2                      Toxicity as monitored by DSMC   \n",
              "3  Anti-tumor activity of GC001: overall response...   \n",
              "4  Postoperative complications | Karnofsky perfor...   \n",
              "\n",
              "                                       Interventions  elig_len  \n",
              "0                                    DRUG:Demcizumab      4781  \n",
              "1                                     DRUG:NP-G2-044      3702  \n",
              "2  DRUG:gemcitabine hydrochloride | DRUG:oxaliplatin      2228  \n",
              "3  BIOLOGICAL:A Phase I Clinical Study of Intratu...      8665  \n",
              "4                   DRUG:Propofol | DRUG:Sevoflurane       726  "
            ]
          },
          "execution_count": 6,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df.head(5)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# Filtering for Systemic Anticancer Trials\n",
        "\n",
        "This section implements high-precision filtering to ensure the dataset contains only relevant interventional systemic anticancer trials Focusing on therapeutic, drug-based interventions Avoiding noise in ML/LLM training"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "fumx_CoxlFJZ"
      },
      "outputs": [],
      "source": [
        "def is_systemic_anticancer_trial(row):\n",
        "    text = \" \".join([\n",
        "        str(row.get('Title', '')),\n",
        "        str(row.get('Official_Title', '')),\n",
        "        str(row.get('Brief_Summary', '')),\n",
        "        str(row.get('Eligibility', '')),\n",
        "        str(row.get('Conditions', '')),\n",
        "        str(row.get('Interventions', ''))\n",
        "    ]).lower()\n",
        "\n",
        "    # HARD EXCLUDE — non-drug / procedural / local therapy\n",
        "    junk_keywords = [\n",
        "        # Locoregional / ablation / device\n",
        "        \"hifu\", \"radiofrequency ablation\", \"rfa\", \"cryoablation\", \"microwave ablation\",\n",
        "        \"tace\", \"deb-tace\", \"y90\", \"radioembolization\", \"sir-spheres\", \"therasphere\",\n",
        "        \"hepatic arterial\", \"haic\", \"chemoembolization\", \"embolization\",\n",
        "        \"sbrt\", \"cyberknife\", \"gamma knife\", \"stereotactic body\", \"stereotactic radiosurgery\",\n",
        "        \"brachytherapy\", \"hdr \", \"intrathecal\", \"lumbar puncture\", \"pleurodesis\",\n",
        "        \"thoracentesis\", \"paracentesis\", \"pleural catheter\", \"chest tube\", \"pleurx\",\n",
        "\n",
        "        # Surgical / diagnostic procedures\n",
        "        \"surgery\", \"resection\", \"lobectomy\", \"wedge resection\", \"thoracoscopic\", \"vats\", \"ivats\",\n",
        "        \"biopsy only\", \"diagnostic biopsy\", \"tissue collection\",\n",
        "\n",
        "        # Prevention / screening / supportive care\n",
        "        \"prevention\", \"chemoprevention\", \"smoking cessation\", \"aspirin\", \"statin\",\n",
        "        \"screening\", \"early detection\", \"surveillance\",\n",
        "\n",
        "        # Non-cancer or minimal anticancer intent\n",
        "        \"supportive care\", \"palliative care only\", \"best supportive care\", \"placebo\",\n",
        "        \"radiation only\", \"radiotherapy alone\", \"radiation therapy as single modality\",\n",
        "\n",
        "        # Others\n",
        "        \"stage iiia\", \"stage iii\", \"inoperable locally advanced\", \"concurrent chemoradiation\", \"definitive chemoradiation\",\n",
        "        \"induction chemotherapy.*allowed\", \"no study drug\", \"radiation therapy.*primary\", \"thoracic radiation\"\n",
        "    ]\n",
        "    if any(kw in text for kw in junk_keywords):\n",
        "        return False\n",
        "\n",
        "    # Must have at least ONE real anticancer drug keyword\n",
        "    drug_keywords = [\n",
        "        \"chemotherapy\", \"targeted therapy\", \"immunotherapy\", \"pd-1\", \"pd-l1\", \"ctla-4\",\n",
        "        \"parp inhibitor\", \"tkis\", \"egfr\", \"alk \", \"braf\", \"mek\", \"mtor\", \"pi3k\",\n",
        "        \"cdk4/6\", \"bcl-2\", \"antibody-drug conjugate\", \"adc\", \"bispecific\",\n",
        "        \"car-t\", \"tcr-t\", \"til therapy\", \"vaccine\", # (vaccine often therapeutic in oncology)\n",
        "        \"olaparib\", \"osimertinib\", \"pembrolizumab\", \"nivolumab\", \"atezolizumab\",\n",
        "        \"bevacizumab\", \"trastuzumab\", \"cetuximab\", \"ramucirumab\", \"everolimus\",\n",
        "        \"lenvatinib\", \"sunitinib\", \"pazopanib\", \"cabozantinib\", \"regorafenib\"\n",
        "    ]\n",
        "    if not any(kw in text for kw in drug_keywords):\n",
        "        return False\n",
        "\n",
        "    # Must contain at least one of these strong signals\n",
        "    strong_signals = [\n",
        "        \"phase 1\", \"phase i\", \"phase 2\", \"phase ii\", \"phase 3\", \"phase iii\",\n",
        "        \"dose escalation\", \"maximum tolerated dose\", \"recommended phase 2 dose\",\n",
        "        \"progression-free survival\", \"overall survival\", \"objective response rate\",\n",
        "        \"recist\", \"irrc\", \"pfs\", \"os\", \"orr\", \"dcr\"\n",
        "    ]\n",
        "    if not any(signal in text for signal in strong_signals):\n",
        "        return False\n",
        "\n",
        "    return True\n",
        "\n",
        "\n",
        "# Apply\n",
        "df = df[\n",
        "    (df['Study_Type'] == 'INTERVENTIONAL') &\n",
        "    df.apply(is_systemic_anticancer_trial, axis=1)\n",
        "].copy()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "DcW9LqMglS5Y",
        "outputId": "46904c53-1dea-4c50-e344-67ecbc3c3b1f"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "After filtering, only 4 rows remain (≤100), keeping all.\n"
          ]
        }
      ],
      "source": [
        "\n",
        "# Keep only rows where 300 <= elig_len <= 3500\n",
        "df_filtered = df[(df['elig_len'] <= 3500) & (df['elig_len'] >= 300)].copy()\n",
        "\n",
        "\n",
        "if len(df_filtered) > 100:\n",
        "    df_filtered = df_filtered.sample(n=100, random_state=2)\n",
        "else:\n",
        "    print(f\"After filtering, only {len(df_filtered)} rows remain (≤100), keeping all.\")\n",
        "\n",
        "# Reset index\n",
        "df = df_filtered.reset_index(drop=True)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "# LLM-Based Eligibility Extraction\n",
        "This section defines extract_eligibility, a robust wrapper to convert unstructured trial eligibility text into a strict JSON schema using a Large Language Model (LLM)."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "rn0nvDj-lWno",
        "outputId": "4035b10e-acb3-4d90-a08e-a642d0f75042"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Get your free key at https://console.groq.com/keys → ··········\n"
          ]
        }
      ],
      "source": [
        "#Seting up Groq client\n",
        "\n",
        "from groq import Groq\n",
        "from getpass import getpass\n",
        "\n",
        "GROQ_API_KEY = getpass(\"Get your free key at https://console.groq.com/keys → \")\n",
        "client = Groq(api_key=GROQ_API_KEY)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "l1yuxc_7lWtA"
      },
      "outputs": [],
      "source": [
        "# ─────────────────────────────────────────────────────────────\n",
        "# FINAL SYSTEM PROMPT\n",
        "# ─────────────────────────────────────────────────────────────\n",
        "SYSTEM_PROMPT = \"\"\"\n",
        "You are a world-class, high-precision clinical trial eligibility parser specialized in oncology interventional therapeutic trials. Your only job is to output perfect, strictly valid JSON using the exact schema below. Never add, remove, or rename any field. Never output explanations, markdown, or extra text.\n",
        "\n",
        "### MANDATORY SCHEMA (use EXACTLY this structure)\n",
        "{\n",
        "  \"trial_id\": null,\n",
        "  \"trial_category\": \"therapeutic_interventional\",\n",
        "  \"age\": {\"min\": 18, \"max\": null},\n",
        "  \"region_specific_age\": {\"japan_min\": null},\n",
        "  \"inclusion\": {\n",
        "    \"disease\": {\n",
        "      \"confirmed_by\": null,\n",
        "      \"cancer_type\": \"\",\n",
        "      \"histology_subtype\": \"\",\n",
        "      \"stage\": \"\",\n",
        "      \"stage_list\": [],\n",
        "      \"metastatic\": null,\n",
        "      \"measurable_disease_recist\": null,\n",
        "      \"biomarker_required\": []\n",
        "    },\n",
        "    \"performance_status\": {\n",
        "      \"scale\": null,\n",
        "      \"min\": null,\n",
        "      \"max\": null\n",
        "    },\n",
        "    \"life_expectancy_weeks\": null,\n",
        "    \"prior_therapy\": {\n",
        "      \"required\": [],\n",
        "      \"allowed\": [],\n",
        "      \"disallowed\": [],\n",
        "      \"max_lines_systemic\": null,\n",
        "      \"washout_weeks\": {\n",
        "        \"chemotherapy\": null,\n",
        "        \"targeted_therapy\": null,\n",
        "        \"immunotherapy\": null,\n",
        "        \"investigational\": null,\n",
        "        \"radiation\": null,\n",
        "        \"major_surgery\": null\n",
        "      }\n",
        "    },\n",
        "    \"brain_metastases\": null,\n",
        "    \"brain_mets_stable_duration_weeks\": null,\n",
        "    \"organ_function\": {\n",
        "      \"anc\": null,\n",
        "      \"platelets\": null,\n",
        "      \"hemoglobin_g_per_dl\": null,\n",
        "      \"creatinine_clearance_ml_min\": null,\n",
        "      \"bilirubin_x_uln\": null,\n",
        "      \"ast_alt_x_uln\": null,\n",
        "      \"albumin_g_per_dl\": null\n",
        "    },\n",
        "    \"cardiac\": {\n",
        "      \"qtcf_ms_max\": null,\n",
        "      \"recent_mi_months_exclusion\": null,\n",
        "      \"nyha_class_max\": null,\n",
        "      \"lvef_percent_min\": null\n",
        "    },\n",
        "    \"contraception_required\": null,\n",
        "    \"other_inclusions\": []\n",
        "  },\n",
        "  \"exclusion\": {\n",
        "    \"pregnant_or_breastfeeding\": null,\n",
        "    \"active_cns_metastases\": null,\n",
        "    \"uncontrolled_intercurrent_illness\": null,\n",
        "    \"grade_2_or_higher_neuropathy\": null,\n",
        "    \"history_of\": [],\n",
        "    \"concurrent_medications_disallowed\": [],\n",
        "    \"other_exclusions\": []\n",
        "  }\n",
        "}\n",
        "\n",
        "### STRICT RULES & CONVENTIONS (follow exactly)\n",
        "\n",
        "1. Age\n",
        "   - Default \"min\": 18 unless explicitly different\n",
        "   - Japan-specific pediatric trials → fill japan_min only\n",
        "\n",
        "2. Performance Status\n",
        "   - Convert everything to ECOG 0–5 scale\n",
        "   - Karnofsky 70–100 → ECOG 0–1 (\"min\": 0, \"max\": 1)\n",
        "   - Karnofsky ≥70 → \"max\": 1\n",
        "   - ECOG ≤1 → \"max\": 1\n",
        "   - Always fill \"scale\": \"ECOG\"\n",
        "\n",
        "3. Brain Metastases – ONLY use these 5 values:\n",
        "   null | \"excluded\" | \"allowed_if_asymptomatic\" | \"allowed_if_stable\" | \"allowed_if_treated_and_stable\"\n",
        "   - If stable duration specified → fill brain_mets_stable_duration_weeks\n",
        "   - \"Symptomatic\", \"uncontrolled\", \"requiring steroids\" → \"excluded\"\n",
        "\n",
        "4. Biomarkers\n",
        "   - Use exact wording from trial: \"ALK positive by FDA-approved test\", \"EGFR exon 19 del or L858R\", \"PD-L1 TPS ≥50%\", \"BRCA1/2 mutated\", \"MSI-H/dMMR\"\n",
        "\n",
        "5. Prior Therapy\n",
        "   - \"max_lines_systemic\" = total systemic lines (not including adjuvant)\n",
        "   - \"required\" = must have received\n",
        "   - \"disallowed\" = must NOT have received\n",
        "\n",
        "6. Lab Values – ALWAYS normalize\n",
        "   - Bilirubin ≤1.5 mg/dL → \"bilirubin_x_uln\": 1.5\n",
        "   - AST/ALT ≤3×ULN (≤5× if liver mets) → \"ast_alt_x_uln\": 3 + note exception in other_inclusions\n",
        "   - Hemoglobin ≥9 g/dL → \"hemoglobin_g_per_dl\": 9\n",
        "\n",
        "7. Life Expectancy\n",
        "   - ≥3 months = 12, ≥6 months = 24, ≥12 months = 52\n",
        "\n",
        "8. Contraception\n",
        "   - Any mention of highly effective contraception → \"contraception_required\": true\n",
        "\n",
        "9. cancer_type & histology_subtype\n",
        "   - cancer_type: \"non-small cell lung cancer\", \"hepatocellular carcinoma\", \"urothelial carcinoma\"\n",
        "   - histology_subtype: \"adenocarcinoma\", \"squamous\", \"small cell\", \"clear cell RCC\"\n",
        "\n",
        "10. NEVER leave critical fields null if information exists\n",
        "    - If ECOG mentioned → fill performance_status\n",
        "    - If any labs mentioned → fill organ_function\n",
        "    - If any prior therapy rules → fill prior_therapy\n",
        "\n",
        "11. other_inclusions / other_exclusions\n",
        "    - Short, precise bullets only\n",
        "    - Examples:\n",
        "      \"Archival tumor tissue required\"\n",
        "      \"Liver metastases: AST/ALT ≤5×ULN allowed\"\n",
        "      \"Able to swallow tablets\"\n",
        "      \"No active autoimmune disease requiring systemic treatment in past 2 years\"\n",
        "\n",
        "Only output raw JSON. No ```json wrapper, no extra characters, no thinking step.\n",
        "\n",
        "Now parse the following trial eligibility text:\n",
        "\"\"\"\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "iPRsKrEzMwM0"
      },
      "outputs": [],
      "source": [
        "\n",
        "# ─────────────────────────────────────────────────────────────\n",
        "# FINAL EXTRACTION FUNCTION\n",
        "# ─────────────────────────────────────────────────────────────\n",
        "def extract_eligibility(\n",
        "    text: str,\n",
        "    client,\n",
        "    model: str = \"meta-llama/llama-4-maverick-17b-128e-instruct\",\n",
        "    max_retries: int = 3\n",
        ") -> Dict[str, Any]:\n",
        "\n",
        "\n",
        "    \"\"\"\n",
        "    Parse unstructured clinical trial eligibility text into a structured JSON format \n",
        "    using an LLM with a strict schema.\n",
        "\n",
        "    Args:\n",
        "        text (str): Raw eligibility criteria text from a clinical trial.\n",
        "        client: LLM API client (e.g., Groq) used for inference.\n",
        "        model (str, optional): LLM model identifier. Defaults to a Meta-LLaMA model.\n",
        "        max_retries (int, optional): Number of retries for API failures. Defaults to 3.\n",
        "\n",
        "    Returns:\n",
        "        Dict[str, Any]: A dictionary following the strict clinical eligibility JSON schema.\n",
        "\n",
        "    Raises:\n",
        "        ValueError: If input text is empty or LLM output is invalid.\n",
        "        RuntimeError: If extraction fails after all retries.\n",
        "    \"\"\"\n",
        "\n",
        "\n",
        "    if not text or not text.strip():\n",
        "        raise ValueError(\"Empty eligibility text\")\n",
        "\n",
        "    for attempt in range(max_retries):\n",
        "        try:\n",
        "            response = client.chat.completions.create(\n",
        "                model=model,\n",
        "                messages=[\n",
        "                    {\"role\": \"system\", \"content\": SYSTEM_PROMPT},\n",
        "                    {\"role\": \"user\", \"content\": text}\n",
        "                ],\n",
        "                temperature=0.0, # deterministic output for reproducible JSON\n",
        "                top_p=1.0, # use full distribution for completeness\n",
        "                max_tokens=3000, # large enough to capture long trial eligibility text\n",
        "                timeout=90\n",
        "            )\n",
        "\n",
        "            raw = response.choices[0].message.content.strip()\n",
        "\n",
        "            # Remove any accidental wrappers\n",
        "            raw = re.sub(r\"^```json\\s*\", \"\", raw, flags=re.IGNORECASE)\n",
        "            raw = re.sub(r\"^```\\s*\", \"\", raw)\n",
        "            raw = re.sub(r\"```$\", \"\", raw)\n",
        "            raw = raw.strip()\n",
        "\n",
        "            if not raw.startswith(\"{\"):\n",
        "                raise ValueError(\"Output does not start with {\")\n",
        "\n",
        "            # Find first complete JSON object\n",
        "            brace_level = 0\n",
        "            end_idx = None\n",
        "            for i, char in enumerate(raw):\n",
        "                if char == '{': brace_level += 1\n",
        "                if char == '}': brace_level -= 1\n",
        "                if brace_level == 0:\n",
        "                    end_idx = i + 1\n",
        "                    break\n",
        "            if end_idx is None:\n",
        "                raise ValueError(\"Unbalanced braces\")\n",
        "\n",
        "            json_str = raw[:end_idx]\n",
        "            result = json.loads(json_str)\n",
        "\n",
        "            # Basic validation\n",
        "            if not isinstance(result, dict) or \"inclusion\" not in result:\n",
        "                raise ValueError(\"Invalid top-level structure\")\n",
        "\n",
        "            # Final safety: ensure performance_status scale is ECOG\n",
        "            ps = result[\"inclusion\"].get(\"performance_status\", {})\n",
        "            if ps.get(\"scale\") in [None, \"\"]:\n",
        "                ps[\"scale\"] = \"ECOG\"\n",
        "\n",
        "            return result\n",
        "\n",
        "        except Exception as e:\n",
        "            print(f\"[Attempt {attempt + 1}] Failed: {e}\")\n",
        "            if attempt < max_retries - 1:\n",
        "                time.sleep(2 ** attempt)\n",
        "                continue\n",
        "            else:\n",
        "                raise RuntimeError(f\"Eligibility parsing failed after {max_retries} attempts\") from e\n",
        "\n",
        "    raise RuntimeError(\"extract_eligibility_perfect exited unexpectedly\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "CBh6f5eGljdz",
        "outputId": "48a88d00-2839-48aa-a50f-254421d73d25"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "100%|██████████| 4/4 [00:21<00:00,  5.29s/it]\n"
          ]
        }
      ],
      "source": [
        "tqdm.pandas()\n",
        "\n",
        "df[\"eligibility_json\"] = df[\"Eligibility\"].progress_apply(\n",
        "    lambda x: extract_eligibility(x, client=client)\n",
        ")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "i9GyNaMYNNgp"
      },
      "outputs": [],
      "source": [
        "pd.set_option('display.max_colwidth', None)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "oDJNcSGklkur",
        "outputId": "a7094662-c103-4615-f2e9-6faf4e8bebb9"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"df[[\\\"eligibility_json\\\",\\\"Eligibility\\\"] ]\",\n  \"rows\": 4,\n  \"fields\": [\n    {\n      \"column\": \"eligibility_json\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Eligibility\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"Inclusion Criteria: * Before the start of the study, All patients have been fully understood the reseach and the must sign the informed consent * To be aged from 18 to 75 years old, both gender * The lung cancer diagnosis must be proved by pathology * According to RECIST (version 1.1), At least 1 objectively measurable Tumor lesion (iconography: CT, MRI), the assessable lesion can be measured accurately, maximum diameter more than at least 10mm (Malignant lymph nodes on CT scans short diameter less than at least 15 mm) * Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 * Lung function FEV1 more than at least 1Land more than 50% A normal value * The function of each organ is basically normal :ANC more than 1.5\\\\*10\\\\^9/L, Platelet count more than 100\\\\*10\\\\^9/L, Hb more than 9.0g/dl, BIL at normal level or less than 1.5\\\\*ULN, AST (SGOT), ALT (SGPT) less than 2.5\\\\*ULN(less than 5\\\\*ULN, if with liver metastases), SCr less than 1.5\\\\*ULN * The expected survival tme must more than 6 months. Exclusion Criteria: * Lung or mediastinal have received radiotherapy before or ever treated with Compound Kushen Injection within 2weeks * Pregnancy or lactation women * Patients with severe, uncontrolled organic lesions or infection, such as decompensated heart, lung, kidney failure can lead to tolerance of chemotherapy - Participating or within the last 30 days participated in other clinical trials * Hypersensitiveness to any kind of trial regime * Had a history of serious Psychological or Psychiatric disorders, Drug addiction or Alcohol dependence * Estimating the compliance of patients to participate in this clinical trial is insufficient.\",\n          \"Key Inclusion Criteria: * Participant has histologically or cytologically confirmed metastatic NSCLC (stage IV with known subtype). * Participant has progressed radiographically on or after receiving: * One prior line of therapy (PD-1/PD-L1 inhibitor and platinum-based chemotherapy concomitantly) in the metastatic disease setting; OR * No more than 2 prior lines of therapy (PD-1/PD-L1 inhibitor and platinum-based chemotherapy sequentially, irrespective of the order) in the metastatic disease setting. * Participant must have positive tumor PD-L1 expression (tumor cells \\u22651%) determined prospectively on a tumor sample from the metastatic setting at a sponsor-designated central laboratory. * Participant has measurable disease according to RECIST v1.1 as assessed by the investigator at baseline. * Participant has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 within 7 days of Cycle 1 Day 1. * Participant has a life expectancy of \\u22653 months. * Participant must have adequate organ and bone marrow function, per laboratory test results within 7 days of trial treatment. Key Exclusion Criteria: * Documentation of known targetable epidermal growth factor receptor (EGFR) sensitizing mutations, anaplastic lymphoma kinase (ALK), RET proto-oncogene (RET), ROS proto-oncogene 1; receptor tyrosine kinase (ROS1) rearrangement, Kirsten rat sarcoma virus (KRAS), B-Raf proto-oncogene (BRAF) mutations, and MET proto-oncogene; receptor tyrosine kinase (MET) exon 14 skipping mutations/MET amplification. NOTE: MET amplification testing is optional based on local availability of the test. * Participants with known KRAS/BRAF mutations are eligible for the trial if they do not have access to approved targeted therapies. * Participants with newly identified or known unstable or symptomatic central nervous system (CNS) metastases or history of carcinomatous meningitis. * Prior treatment with docetaxel for NSCLC. * Prior treatment with a 4-1BB (CD137) targeted agent, any type of antitumor vaccine, autologous cell immunotherapy, or any unapproved immunotherapy. * Treatment with an anticancer agent within 28 days prior to the first dose of trial treatment. Note: Other protocol-defined inclusion and exclusion criteria may apply.\",\n          \"Inclusion Criteria: * Histologically proven lung cancer * Inoperable * Non-Small Cell Cancer * Partial or total bronchial obstruction responsible for functional signs * T1 to T4, N0-N3, M0-M1 * Patients with functional signs: hemoptysis, infection, cough and, above all, dyspnea * Contralateral metastases not representing a contraindication insofar as they do not represent a risk of impairment of respiratory function during treatment * The Karnofsky index should be greater than or equal to 40 * Patients should agree to and tolerate repeated bronchial endoscopy (a disadvantage of all endoscopic treatments) * Male or female patients aged over 18 years, female patients should not be pregnant (menopause or contraception) * Patients should have given their written consent to take part in the study Exclusion Criteria: * Tracheal lesions and lesions affecting the carina tracheae * Patients with painful bone metastases (not an absolute criterion since the extent of dyspnea is the decisive element) * Patients with brain metastases * Patients having undergone pneumonectomy * Patients undergoing chemotherapy or radiotherapy or having undergone chemotherapy less than 4 weeks before the procedure or radiotherapy less than 4 weeks before the procedure * Patients with risk of large vessel erosion or perforation resulting from lesion topography * In case of allergy to the photosensitizer * Leukopenia (WBC\\\\<2000), Thrombocytopenia (\\\\< 100 000), PT \\\\> 1.5 normal, Fibrinogen \\\\< 2g/l, a PTT \\\\> 1.5 ULN (Upper Limit of Normal) * Renal insufficiency * Hepatic insufficiency * Patients having already received 70 Gy on the lesion * Existing tracheoesophageal or bronchoesophageal fistula * Emergency treatment of patients with severe acute respiratory distress caused by an obstructing endobronchial lesion\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-ca26596c-5250-451e-a624-84b2cd0354de\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>eligibility_json</th>\n",
              "      <th>Eligibility</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'T1 to T4, N0-N3, M0-M1', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 3}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to tolerate repeated bronchial endoscopy', 'Written consent given']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Tracheal lesions or lesions affecting carina tracheae', 'Painful bone metastases', 'Previous pneumonectomy', 'Risk of large vessel erosion or perforation', 'Allergy to photosensitizer', 'Leukopenia (WBC&lt;2000)', 'Thrombocytopenia (&lt;100000)', 'PT &gt;1.5 normal', 'Fibrinogen &lt;2g/l', 'PTT &gt;1.5 ULN', 'Renal insufficiency', 'Hepatic insufficiency', 'Previous 70 Gy radiation on lesion', 'Existing tracheoesophageal or bronchoesophageal fistula', 'Severe acute respiratory distress']}}</td>\n",
              "      <td>Inclusion Criteria: * Histologically proven lung cancer * Inoperable * Non-Small Cell Cancer * Partial or total bronchial obstruction responsible for functional signs * T1 to T4, N0-N3, M0-M1 * Patients with functional signs: hemoptysis, infection, cough and, above all, dyspnea * Contralateral metastases not representing a contraindication insofar as they do not represent a risk of impairment of respiratory function during treatment * The Karnofsky index should be greater than or equal to 40 * Patients should agree to and tolerate repeated bronchial endoscopy (a disadvantage of all endoscopic treatments) * Male or female patients aged over 18 years, female patients should not be pregnant (menopause or contraception) * Patients should have given their written consent to take part in the study Exclusion Criteria: * Tracheal lesions and lesions affecting the carina tracheae * Patients with painful bone metastases (not an absolute criterion since the extent of dyspnea is the decisive element) * Patients with brain metastases * Patients having undergone pneumonectomy * Patients undergoing chemotherapy or radiotherapy or having undergone chemotherapy less than 4 weeks before the procedure or radiotherapy less than 4 weeks before the procedure * Patients with risk of large vessel erosion or perforation resulting from lesion topography * In case of allergy to the photosensitizer * Leukopenia (WBC\\&lt;2000), Thrombocytopenia (\\&lt; 100 000), PT \\&gt; 1.5 normal, Fibrinogen \\&lt; 2g/l, a PTT \\&gt; 1.5 ULN (Upper Limit of Normal) * Renal insufficiency * Hepatic insufficiency * Patients having already received 70 Gy on the lesion * Existing tracheoesophageal or bronchoesophageal fistula * Emergency treatment of patients with severe acute respiratory distress caused by an obstructing endobronchial lesion</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['FEV1 &gt;1L and &gt;50% normal value', 'AST/ALT ≤5×ULN allowed if liver metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['serious psychological/psychiatric disorders', 'drug addiction', 'alcohol dependence'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous radiotherapy to lung/mediastinum within 2 weeks', 'Previous treatment with Compound Kushen Injection within 2 weeks', 'Participating in other clinical trials within last 30 days', 'Hypersensitivity to trial regimen']}}</td>\n",
              "      <td>Inclusion Criteria: * Before the start of the study, All patients have been fully understood the reseach and the must sign the informed consent * To be aged from 18 to 75 years old, both gender * The lung cancer diagnosis must be proved by pathology * According to RECIST (version 1.1), At least 1 objectively measurable Tumor lesion (iconography: CT, MRI), the assessable lesion can be measured accurately, maximum diameter more than at least 10mm (Malignant lymph nodes on CT scans short diameter less than at least 15 mm) * Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 * Lung function FEV1 more than at least 1Land more than 50% A normal value * The function of each organ is basically normal :ANC more than 1.5\\*10\\^9/L, Platelet count more than 100\\*10\\^9/L, Hb more than 9.0g/dl, BIL at normal level or less than 1.5\\*ULN, AST (SGOT), ALT (SGPT) less than 2.5\\*ULN(less than 5\\*ULN, if with liver metastases), SCr less than 1.5\\*ULN * The expected survival tme must more than 6 months. Exclusion Criteria: * Lung or mediastinal have received radiotherapy before or ever treated with Compound Kushen Injection within 2weeks * Pregnancy or lactation women * Patients with severe, uncontrolled organic lesions or infection, such as decompensated heart, lung, kidney failure can lead to tolerance of chemotherapy - Participating or within the last 30 days participated in other clinical trials * Hypersensitiveness to any kind of trial regime * Had a history of serious Psychological or Psychiatric disorders, Drug addiction or Alcohol dependence * Estimating the compliance of patients to participate in this clinical trial is insufficient.</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Toxic effects of previous therapy recovered to ≤ Grade 1']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Live vaccine within 30 days of study therapy start'], 'other_exclusions': ['Active infection requiring systemic therapy', 'Active or inactive autoimmune disease or syndrome']}}</td>\n",
              "      <td>Inclusion Criteria: * Histologically or cytologically confirmed diagnosis of selected advanced or metastatic solid tumors. * Presence of measurable disease per RECIST v1.1. * Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Exclusion Criteria: * Laboratory and medical history parameters not within the Protocol-defined range. * Receipt of anticancer medications or investigational drugs within the Protocol-defined intervals before the first administration of study drug. * Previous radiotherapy within 2 weeks of starting study therapy. * Known active central nervous system (CNS) metastases and/or carcinomatous meningitis. * Has not recovered to ≤ Grade 1 from toxic effects of previous therapy and/or complications from previous surgical intervention before starting study therapy. * Receipt of a live vaccine within 30 days of planned start of study therapy. * Active infection requiring systemic therapy. * Subjects who have any active or inactive autoimmune disease or syndrome. * Women who are pregnant or breastfeeding.</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>{'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['PD-L1 expression ≥1%']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['PD-1/PD-L1 inhibitor and platinum-based chemotherapy'], 'allowed': [], 'disallowed': ['docetaxel for NSCLC', '4-1BB targeted agent', 'antitumor vaccine', 'autologous cell immunotherapy', 'unapproved immunotherapy'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Tumor sample from metastatic setting required for PD-L1 testing', 'Adequate organ and bone marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Known targetable EGFR mutations', 'Known ALK rearrangement', 'Known RET rearrangement', 'Known ROS1 rearrangement', 'Known MET exon 14 skipping mutations/MET amplification', 'Known KRAS/BRAF mutations with access to approved targeted therapies']}}</td>\n",
              "      <td>Key Inclusion Criteria: * Participant has histologically or cytologically confirmed metastatic NSCLC (stage IV with known subtype). * Participant has progressed radiographically on or after receiving: * One prior line of therapy (PD-1/PD-L1 inhibitor and platinum-based chemotherapy concomitantly) in the metastatic disease setting; OR * No more than 2 prior lines of therapy (PD-1/PD-L1 inhibitor and platinum-based chemotherapy sequentially, irrespective of the order) in the metastatic disease setting. * Participant must have positive tumor PD-L1 expression (tumor cells ≥1%) determined prospectively on a tumor sample from the metastatic setting at a sponsor-designated central laboratory. * Participant has measurable disease according to RECIST v1.1 as assessed by the investigator at baseline. * Participant has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 within 7 days of Cycle 1 Day 1. * Participant has a life expectancy of ≥3 months. * Participant must have adequate organ and bone marrow function, per laboratory test results within 7 days of trial treatment. Key Exclusion Criteria: * Documentation of known targetable epidermal growth factor receptor (EGFR) sensitizing mutations, anaplastic lymphoma kinase (ALK), RET proto-oncogene (RET), ROS proto-oncogene 1; receptor tyrosine kinase (ROS1) rearrangement, Kirsten rat sarcoma virus (KRAS), B-Raf proto-oncogene (BRAF) mutations, and MET proto-oncogene; receptor tyrosine kinase (MET) exon 14 skipping mutations/MET amplification. NOTE: MET amplification testing is optional based on local availability of the test. * Participants with known KRAS/BRAF mutations are eligible for the trial if they do not have access to approved targeted therapies. * Participants with newly identified or known unstable or symptomatic central nervous system (CNS) metastases or history of carcinomatous meningitis. * Prior treatment with docetaxel for NSCLC. * Prior treatment with a 4-1BB (CD137) targeted agent, any type of antitumor vaccine, autologous cell immunotherapy, or any unapproved immunotherapy. * Treatment with an anticancer agent within 28 days prior to the first dose of trial treatment. Note: Other protocol-defined inclusion and exclusion criteria may apply.</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ca26596c-5250-451e-a624-84b2cd0354de')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ca26596c-5250-451e-a624-84b2cd0354de button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ca26596c-5250-451e-a624-84b2cd0354de');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-0ea40d7d-2a3f-4139-8db5-9574033f90a1\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-0ea40d7d-2a3f-4139-8db5-9574033f90a1')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-0ea40d7d-2a3f-4139-8db5-9574033f90a1 button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                eligibility_json  \\\n",
              "0                {'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'T1 to T4, N0-N3, M0-M1', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': None, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 3}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 4, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': 100000, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': True, 'other_inclusions': ['Able to tolerate repeated bronchial endoscopy', 'Written consent given']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Tracheal lesions or lesions affecting carina tracheae', 'Painful bone metastases', 'Previous pneumonectomy', 'Risk of large vessel erosion or perforation', 'Allergy to photosensitizer', 'Leukopenia (WBC<2000)', 'Thrombocytopenia (<100000)', 'PT >1.5 normal', 'Fibrinogen <2g/l', 'PTT >1.5 ULN', 'Renal insufficiency', 'Hepatic insufficiency', 'Previous 70 Gy radiation on lesion', 'Existing tracheoesophageal or bronchoesophageal fistula', 'Severe acute respiratory distress']}}   \n",
              "1                                                                                                                                                                                                                                     {'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': 75}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'pathology', 'cancer_type': 'lung cancer', 'histology_subtype': '', 'stage': '', 'stage_list': [], 'metastatic': None, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': None, 'max': 2}, 'life_expectancy_weeks': 24, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': None, 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': 1.5, 'platelets': 100, 'hemoglobin_g_per_dl': 9, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': 1.5, 'ast_alt_x_uln': 2.5, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['FEV1 >1L and >50% normal value', 'AST/ALT ≤5×ULN allowed if liver metastases']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': None, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': ['serious psychological/psychiatric disorders', 'drug addiction', 'alcohol dependence'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Previous radiotherapy to lung/mediastinum within 2 weeks', 'Previous treatment with Compound Kushen Injection within 2 weeks', 'Participating in other clinical trials within last 30 days', 'Hypersensitivity to trial regimen']}}   \n",
              "2                                                                                                                                                                                                                                                                                                                                                                        {'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'solid tumors', 'histology_subtype': '', 'stage': 'advanced or metastatic', 'stage_list': [], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': []}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': None, 'prior_therapy': {'required': [], 'allowed': [], 'disallowed': [], 'max_lines_systemic': None, 'washout_weeks': {'chemotherapy': None, 'targeted_therapy': None, 'immunotherapy': None, 'investigational': None, 'radiation': 2, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Toxic effects of previous therapy recovered to ≤ Grade 1']}, 'exclusion': {'pregnant_or_breastfeeding': True, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': True, 'grade_2_or_higher_neuropathy': None, 'history_of': [], 'concurrent_medications_disallowed': ['Live vaccine within 30 days of study therapy start'], 'other_exclusions': ['Active infection requiring systemic therapy', 'Active or inactive autoimmune disease or syndrome']}}   \n",
              "3  {'trial_id': None, 'trial_category': 'therapeutic_interventional', 'age': {'min': 18, 'max': None}, 'region_specific_age': {'japan_min': None}, 'inclusion': {'disease': {'confirmed_by': 'histology or cytology', 'cancer_type': 'non-small cell lung cancer', 'histology_subtype': '', 'stage': 'IV', 'stage_list': ['IV'], 'metastatic': True, 'measurable_disease_recist': True, 'biomarker_required': ['PD-L1 expression ≥1%']}, 'performance_status': {'scale': 'ECOG', 'min': 0, 'max': 1}, 'life_expectancy_weeks': 12, 'prior_therapy': {'required': ['PD-1/PD-L1 inhibitor and platinum-based chemotherapy'], 'allowed': [], 'disallowed': ['docetaxel for NSCLC', '4-1BB targeted agent', 'antitumor vaccine', 'autologous cell immunotherapy', 'unapproved immunotherapy'], 'max_lines_systemic': 2, 'washout_weeks': {'chemotherapy': 4, 'targeted_therapy': 4, 'immunotherapy': 4, 'investigational': 4, 'radiation': None, 'major_surgery': None}}, 'brain_metastases': 'excluded', 'brain_mets_stable_duration_weeks': None, 'organ_function': {'anc': None, 'platelets': None, 'hemoglobin_g_per_dl': None, 'creatinine_clearance_ml_min': None, 'bilirubin_x_uln': None, 'ast_alt_x_uln': None, 'albumin_g_per_dl': None}, 'cardiac': {'qtcf_ms_max': None, 'recent_mi_months_exclusion': None, 'nyha_class_max': None, 'lvef_percent_min': None}, 'contraception_required': None, 'other_inclusions': ['Tumor sample from metastatic setting required for PD-L1 testing', 'Adequate organ and bone marrow function']}, 'exclusion': {'pregnant_or_breastfeeding': None, 'active_cns_metastases': True, 'uncontrolled_intercurrent_illness': None, 'grade_2_or_higher_neuropathy': None, 'history_of': ['carcinomatous meningitis'], 'concurrent_medications_disallowed': [], 'other_exclusions': ['Known targetable EGFR mutations', 'Known ALK rearrangement', 'Known RET rearrangement', 'Known ROS1 rearrangement', 'Known MET exon 14 skipping mutations/MET amplification', 'Known KRAS/BRAF mutations with access to approved targeted therapies']}}   \n",
              "\n",
              "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Eligibility  \n",
              "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Inclusion Criteria: * Histologically proven lung cancer * Inoperable * Non-Small Cell Cancer * Partial or total bronchial obstruction responsible for functional signs * T1 to T4, N0-N3, M0-M1 * Patients with functional signs: hemoptysis, infection, cough and, above all, dyspnea * Contralateral metastases not representing a contraindication insofar as they do not represent a risk of impairment of respiratory function during treatment * The Karnofsky index should be greater than or equal to 40 * Patients should agree to and tolerate repeated bronchial endoscopy (a disadvantage of all endoscopic treatments) * Male or female patients aged over 18 years, female patients should not be pregnant (menopause or contraception) * Patients should have given their written consent to take part in the study Exclusion Criteria: * Tracheal lesions and lesions affecting the carina tracheae * Patients with painful bone metastases (not an absolute criterion since the extent of dyspnea is the decisive element) * Patients with brain metastases * Patients having undergone pneumonectomy * Patients undergoing chemotherapy or radiotherapy or having undergone chemotherapy less than 4 weeks before the procedure or radiotherapy less than 4 weeks before the procedure * Patients with risk of large vessel erosion or perforation resulting from lesion topography * In case of allergy to the photosensitizer * Leukopenia (WBC\\<2000), Thrombocytopenia (\\< 100 000), PT \\> 1.5 normal, Fibrinogen \\< 2g/l, a PTT \\> 1.5 ULN (Upper Limit of Normal) * Renal insufficiency * Hepatic insufficiency * Patients having already received 70 Gy on the lesion * Existing tracheoesophageal or bronchoesophageal fistula * Emergency treatment of patients with severe acute respiratory distress caused by an obstructing endobronchial lesion  \n",
              "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Inclusion Criteria: * Before the start of the study, All patients have been fully understood the reseach and the must sign the informed consent * To be aged from 18 to 75 years old, both gender * The lung cancer diagnosis must be proved by pathology * According to RECIST (version 1.1), At least 1 objectively measurable Tumor lesion (iconography: CT, MRI), the assessable lesion can be measured accurately, maximum diameter more than at least 10mm (Malignant lymph nodes on CT scans short diameter less than at least 15 mm) * Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 * Lung function FEV1 more than at least 1Land more than 50% A normal value * The function of each organ is basically normal :ANC more than 1.5\\*10\\^9/L, Platelet count more than 100\\*10\\^9/L, Hb more than 9.0g/dl, BIL at normal level or less than 1.5\\*ULN, AST (SGOT), ALT (SGPT) less than 2.5\\*ULN(less than 5\\*ULN, if with liver metastases), SCr less than 1.5\\*ULN * The expected survival tme must more than 6 months. Exclusion Criteria: * Lung or mediastinal have received radiotherapy before or ever treated with Compound Kushen Injection within 2weeks * Pregnancy or lactation women * Patients with severe, uncontrolled organic lesions or infection, such as decompensated heart, lung, kidney failure can lead to tolerance of chemotherapy - Participating or within the last 30 days participated in other clinical trials * Hypersensitiveness to any kind of trial regime * Had a history of serious Psychological or Psychiatric disorders, Drug addiction or Alcohol dependence * Estimating the compliance of patients to participate in this clinical trial is insufficient.  \n",
              "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Inclusion Criteria: * Histologically or cytologically confirmed diagnosis of selected advanced or metastatic solid tumors. * Presence of measurable disease per RECIST v1.1. * Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. Exclusion Criteria: * Laboratory and medical history parameters not within the Protocol-defined range. * Receipt of anticancer medications or investigational drugs within the Protocol-defined intervals before the first administration of study drug. * Previous radiotherapy within 2 weeks of starting study therapy. * Known active central nervous system (CNS) metastases and/or carcinomatous meningitis. * Has not recovered to ≤ Grade 1 from toxic effects of previous therapy and/or complications from previous surgical intervention before starting study therapy. * Receipt of a live vaccine within 30 days of planned start of study therapy. * Active infection requiring systemic therapy. * Subjects who have any active or inactive autoimmune disease or syndrome. * Women who are pregnant or breastfeeding.  \n",
              "3  Key Inclusion Criteria: * Participant has histologically or cytologically confirmed metastatic NSCLC (stage IV with known subtype). * Participant has progressed radiographically on or after receiving: * One prior line of therapy (PD-1/PD-L1 inhibitor and platinum-based chemotherapy concomitantly) in the metastatic disease setting; OR * No more than 2 prior lines of therapy (PD-1/PD-L1 inhibitor and platinum-based chemotherapy sequentially, irrespective of the order) in the metastatic disease setting. * Participant must have positive tumor PD-L1 expression (tumor cells ≥1%) determined prospectively on a tumor sample from the metastatic setting at a sponsor-designated central laboratory. * Participant has measurable disease according to RECIST v1.1 as assessed by the investigator at baseline. * Participant has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 within 7 days of Cycle 1 Day 1. * Participant has a life expectancy of ≥3 months. * Participant must have adequate organ and bone marrow function, per laboratory test results within 7 days of trial treatment. Key Exclusion Criteria: * Documentation of known targetable epidermal growth factor receptor (EGFR) sensitizing mutations, anaplastic lymphoma kinase (ALK), RET proto-oncogene (RET), ROS proto-oncogene 1; receptor tyrosine kinase (ROS1) rearrangement, Kirsten rat sarcoma virus (KRAS), B-Raf proto-oncogene (BRAF) mutations, and MET proto-oncogene; receptor tyrosine kinase (MET) exon 14 skipping mutations/MET amplification. NOTE: MET amplification testing is optional based on local availability of the test. * Participants with known KRAS/BRAF mutations are eligible for the trial if they do not have access to approved targeted therapies. * Participants with newly identified or known unstable or symptomatic central nervous system (CNS) metastases or history of carcinomatous meningitis. * Prior treatment with docetaxel for NSCLC. * Prior treatment with a 4-1BB (CD137) targeted agent, any type of antitumor vaccine, autologous cell immunotherapy, or any unapproved immunotherapy. * Treatment with an anticancer agent within 28 days prior to the first dose of trial treatment. Note: Other protocol-defined inclusion and exclusion criteria may apply.  "
            ]
          },
          "execution_count": 20,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "df[[\"eligibility_json\",\"Eligibility\"] ].head()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_rXmESD8lsPj"
      },
      "outputs": [],
      "source": [
        "# ============= Save CSV ============\n",
        "csv_name = \"./data/trials_parsed.csv\"\n",
        "df.to_csv(csv_name, index=False)\n",
        "print(\"Saved:\", csv_name)"
      ]
    }
  ],
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
